Stay updated on Batoclimab in Active Thyroid Eye Disease Clinical Trial
Sign up to get notified when there's something new on the Batoclimab in Active Thyroid Eye Disease Clinical Trial page.

Latest updates to the Batoclimab in Active Thyroid Eye Disease Clinical Trial page
- CheckyesterdayChange DetectedThere are no meaningful additions or deletions to the Study Details page between the two screenshots; core study information remains unchanged.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check30 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%

- Check37 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the previous version v3.0.2 as a reference point.SummaryDifference0.4%

- Check51 days agoChange Detected- The study is now Active, not recruiting (replacing Recruiting/Completed), and the location count increases to 45 with added Mainz site details in Rhineland-Palatinate, Germany. - Revision updated to v3.0.2 with an estimated Last Update posted in September 2025.SummaryDifference4%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as topics related to drug safety and genetics, while removing previous location entries and an older version revision number.SummaryDifference4%

Stay in the know with updates to Batoclimab in Active Thyroid Eye Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Batoclimab in Active Thyroid Eye Disease Clinical Trial page.